Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion type Assertion NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_head.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion wasGeneratedBy ECO_0000203 NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_provenance.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion wasDerivedFrom befree-2016 NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_provenance.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion SIO_000772 20683028 NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_provenance.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion evidence source_evidence_literature NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_provenance.
- NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_assertion description "[The combined effect of CYP1B1*3 polymorphism and NAT2 slow acetylator genotype contributed to an increased risk for breast cancer in patients in this study (p=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830516.RARrzoQe6MrBDFI5TdJ2gKa5sj1j6ewfGYBLd9esH2DWY130_provenance.